Treatment for epidemic keratoconjunctivitis (EKC) is generally supportive, and there is no established antiviral therapy. However, a few reports advocate the off-label use of 5% Betadine (povidone-iodine, Alcon). A new study is now enrolling patients to confirm the effectiveness of a protocol using Betadine to treat acute EKC. To participate, go to